These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 22214904)

  • 1. White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis.
    Cambron M; D'Haeseleer M; Laureys G; Clinckers R; Debruyne J; De Keyser J
    J Cereb Blood Flow Metab; 2012 Mar; 32(3):413-24. PubMed ID: 22214904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytic beta2-adrenergic receptors and multiple sclerosis.
    De Keyser J; Zeinstra E; Wilczak N
    Neurobiol Dis; 2004 Mar; 15(2):331-9. PubMed ID: 15006703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced creatine kinase B activity in multiple sclerosis normal appearing white matter.
    Steen C; Wilczak N; Hoogduin JM; Koch M; De Keyser J
    PLoS One; 2010 May; 5(5):e10811. PubMed ID: 20520825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis.
    Su KG; Banker G; Bourdette D; Forte M
    Curr Neurol Neurosci Rep; 2009 Sep; 9(5):411-7. PubMed ID: 19664372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of mitochondria in axonal degeneration and tissue repair in MS.
    van Horssen J; Witte ME; Ciccarelli O
    Mult Scler; 2012 Aug; 18(8):1058-67. PubMed ID: 22723572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nitric oxide to axonal degeneration in multiple sclerosis via downregulating monocarboxylate transporter 1 in oligodendrocytes.
    Tang X; Lan M; Zhang M; Yao Z
    Nitric Oxide; 2017 Jul; 67():75-80. PubMed ID: 28392448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesions.
    Nijland PG; Michailidou I; Witte ME; Mizee MR; van der Pol SM; van Het Hof B; Reijerkerk A; Pellerin L; van der Valk P; de Vries HE; van Horssen J
    Glia; 2014 Jul; 62(7):1125-41. PubMed ID: 24692237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal MR spectroscopy of neurodegeneration in multiple sclerosis with diffusion of the intra-axonal constituent
    Wood ET; Ercan E; Sati P; Cortese ICM; Ronen I; Reich DS
    Neuroimage Clin; 2017; 15():780-788. PubMed ID: 28702353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
    Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
    J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis.
    Basso AS; Frenkel D; Quintana FJ; Costa-Pinto FA; Petrovic-Stojkovic S; Puckett L; Monsonego A; Bar-Shir A; Engel Y; Gozin M; Weiner HL
    J Clin Invest; 2008 Apr; 118(4):1532-43. PubMed ID: 18340379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Mitochondria and disease progression in multiple sclerosis.
    Mahad D; Lassmann H; Turnbull D
    Neuropathol Appl Neurobiol; 2008 Dec; 34(6):577-89. PubMed ID: 19076696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.
    Wiebenga OT; Klauser AM; Schoonheim MM; Nagtegaal GJ; Steenwijk MD; van Rossum JA; Polman CH; Barkhof F; Pouwels PJ; Geurts JJ
    AJNR Am J Neuroradiol; 2015 Jun; 36(6):1116-23. PubMed ID: 25742985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Energy metabolism in astrocytes: high rate of oxidative metabolism and spatiotemporal dependence on glycolysis/glycogenolysis.
    Hertz L; Peng L; Dienel GA
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):219-49. PubMed ID: 16835632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for the maintenance and regulation of axonal energy supply.
    Chamberlain KA; Sheng ZH
    J Neurosci Res; 2019 Aug; 97(8):897-913. PubMed ID: 30883896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 2-adrenoceptor involvement in inflammatory demyelination and axonal degeneration in multiple sclerosis.
    De Keyser J; Zeinstra E; Mostert J; Wilczak N
    Trends Pharmacol Sci; 2004 Feb; 25(2):67-71. PubMed ID: 15102491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
    Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
    J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
    Steen C; D'haeseleer M; Hoogduin JM; Fierens Y; Cambron M; Mostert JP; Heersema DJ; Koch MW; De Keyser J
    Mult Scler; 2013 Sep; 19(10):1282-9. PubMed ID: 23428956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica.
    Wegner C
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S38-41. PubMed ID: 24321153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis: altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage.
    Werner P; Pitt D; Raine CS
    Ann Neurol; 2001 Aug; 50(2):169-80. PubMed ID: 11506399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The central role of mitochondria in axonal degeneration in multiple sclerosis.
    Campbell GR; Worrall JT; Mahad DJ
    Mult Scler; 2014 Dec; 20(14):1806-13. PubMed ID: 25122475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.